43063-0438 Medroxyprogesterone Acetate

Product NDC:

43063-0438

Brand Name:

Medroxyprogesterone Acetate

Generic Name:

Medroxyprogesterone Acetate

Dosage Form Name:

Tablet

Administration Route:

Oral

Substances:

Name: Medroxyprogesterone Acetate

Strength: 10.0

Unit: mg/1

Packages:

Code: 43063-0438-05

Description: 5 TABLET in 1 BOTTLE, PLASTIC (43063-438-05)

Effective Date: March 1, 2013

Discontinued: Dec. 31, 2022

Code: 43063-0438-07

Description: 7 TABLET in 1 BOTTLE, PLASTIC (43063-438-07)

Effective Date: March 1, 2013

Discontinued: Dec. 31, 2022

Code: 43063-0438-10

Description: 10 TABLET in 1 BOTTLE, PLASTIC (43063-438-10)

Effective Date: March 1, 2013

Discontinued: Dec. 31, 2022

Code: 43063-0438-13

Description: 13 TABLET in 1 BOTTLE, PLASTIC (43063-438-13)

Effective Date: March 1, 2013

Discontinued: Dec. 31, 2022

Code: 43063-0438-30

Description: 30 TABLET in 1 BOTTLE, PLASTIC (43063-438-30)

Effective Date: March 1, 2013

Discontinued: Dec. 31, 2022

Code: 43063-0438-40

Description: 40 TABLET in 1 BOTTLE, PLASTIC (43063-438-40)

Effective Date: March 1, 2013

Discontinued: Dec. 31, 2022

Code: 43063-0438-42

Description: 42 TABLET in 1 BOTTLE, PLASTIC (43063-438-42)

Effective Date: March 1, 2013

Discontinued: Dec. 31, 2022

Code: 43063-0438-50

Description: 50 TABLET in 1 BOTTLE, PLASTIC (43063-438-50)

Effective Date: March 1, 2013

Discontinued: Dec. 31, 2022

Code: 43063-0438-90

Description: 90 TABLET in 1 BOTTLE, PLASTIC (43063-438-90)

Effective Date: March 1, 2013

Discontinued: Dec. 31, 2022

SEER*Rx Category:

Hormonal Therapy

Major Class:

Progestin

Minor Class:

Orphan Drug Designation:

Status:

In Use

CanMED and the Oncology Toolbox

CanMED: NDC